Ikena Oncology (IKNA) Competitors $1.38 -0.01 (-0.72%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.38 0.00 (0.00%) As of 07/11/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IKNA vs. ZYBT, TKNO, SGMT, CRVS, CRDF, TSVT, ALLO, TNXP, CADL, and INZYShould you be buying Ikena Oncology stock or one of its competitors? The main competitors of Ikena Oncology include Zhengye Biotechnology (ZYBT), Alpha Teknova (TKNO), Sagimet Biosciences (SGMT), Corvus Pharmaceuticals (CRVS), Cardiff Oncology (CRDF), 2seventy bio (TSVT), Allogene Therapeutics (ALLO), Tonix Pharmaceuticals (TNXP), Candel Therapeutics (CADL), and Inozyme Pharma (INZY). These companies are all part of the "pharmaceutical products" industry. Ikena Oncology vs. Its Competitors Zhengye Biotechnology Alpha Teknova Sagimet Biosciences Corvus Pharmaceuticals Cardiff Oncology 2seventy bio Allogene Therapeutics Tonix Pharmaceuticals Candel Therapeutics Inozyme Pharma Zhengye Biotechnology (NASDAQ:ZYBT) and Ikena Oncology (NASDAQ:IKNA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends. Is ZYBT or IKNA more profitable? Zhengye Biotechnology's return on equity of 0.00% beat Ikena Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Zhengye BiotechnologyN/A N/A N/A Ikena Oncology N/A -30.59%-27.55% Does the media favor ZYBT or IKNA? In the previous week, Ikena Oncology had 4 more articles in the media than Zhengye Biotechnology. MarketBeat recorded 5 mentions for Ikena Oncology and 1 mentions for Zhengye Biotechnology. Zhengye Biotechnology's average media sentiment score of 1.89 beat Ikena Oncology's score of 0.95 indicating that Zhengye Biotechnology is being referred to more favorably in the media. Company Overall Sentiment Zhengye Biotechnology Very Positive Ikena Oncology Positive Which has stronger valuation & earnings, ZYBT or IKNA? Zhengye Biotechnology has higher revenue and earnings than Ikena Oncology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZhengye Biotechnology$25.53M10.88N/AN/AN/AIkena Oncology$9.16M7.27-$49.23M-$0.86-1.60 Do institutionals & insiders believe in ZYBT or IKNA? 75.0% of Ikena Oncology shares are held by institutional investors. 5.9% of Ikena Oncology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts rate ZYBT or IKNA? Ikena Oncology has a consensus price target of $3.00, indicating a potential upside of 117.39%. Given Ikena Oncology's stronger consensus rating and higher possible upside, analysts plainly believe Ikena Oncology is more favorable than Zhengye Biotechnology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zhengye Biotechnology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ikena Oncology 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryIkena Oncology beats Zhengye Biotechnology on 6 of the 11 factors compared between the two stocks. Get Ikena Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for IKNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IKNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IKNA vs. The Competition Export to ExcelMetricIkena OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$67.08M$2.98B$5.60B$9.10BDividend YieldN/A2.39%5.24%4.00%P/E Ratio-1.6020.5827.9620.25Price / Sales7.27291.32429.2099.14Price / CashN/A42.8637.4658.16Price / Book0.537.638.045.49Net Income-$49.23M-$55.05M$3.18B$250.27M7 Day Performance3.76%8.39%3.63%4.75%1 Month Performance0.73%5.35%4.04%7.64%1 Year Performance-19.30%1.95%29.56%16.34% Ikena Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IKNAIkena Oncology2.7779 of 5 stars$1.38-0.7%$3.00+117.4%-16.4%$67.08M$9.16M-1.6070News CoverageZYBTZhengye BiotechnologyN/A$5.73+3.4%N/AN/A$270.26M$189.75M0.00278Positive NewsLockup ExpirationGap DownTKNOAlpha Teknova2.2382 of 5 stars$5.06+1.3%$8.50+68.2%+287.9%$269.34M$37.74M-10.50240Positive NewsSGMTSagimet Biosciences3.0045 of 5 stars$8.75+0.8%$26.60+204.0%+189.6%$268.33M$2M-4.978CRVSCorvus Pharmaceuticals2.8687 of 5 stars$3.94+0.9%$15.00+281.2%+109.1%$267.91MN/A-4.0130Positive NewsCRDFCardiff Oncology1.2844 of 5 stars$4.03+10.3%$11.70+190.7%+64.8%$266.79M$680K-4.3620Analyst ForecastTSVT2seventy bioN/A$5.00flat$5.00N/A$266.15M$48.37M-2.69440ALLOAllogene Therapeutics3.4712 of 5 stars$1.22+4.7%$8.44+595.0%-52.2%$263.57M$20K-0.98310News CoveragePositive NewsGap UpTNXPTonix Pharmaceuticals2.6667 of 5 stars$35.22-0.6%$585.00+1,561.0%-33.1%$258.49M$10.04M-0.0250Trending NewsCADLCandel Therapeutics2.4697 of 5 stars$5.18+3.7%$22.00+325.1%-1.7%$258.28MN/A-3.8560Positive NewsAnalyst UpgradeAnalyst RevisionINZYInozyme Pharma3.2832 of 5 stars$4.00flat$11.75+193.8%N/A$258.25MN/A-2.3750 Related Companies and Tools Related Companies ZYBT Competitors TKNO Competitors SGMT Competitors CRVS Competitors CRDF Competitors TSVT Competitors ALLO Competitors TNXP Competitors CADL Competitors INZY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IKNA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored"I'm risking my reputation on this"Most people think you need thousands to profit from crypto. But this free book exposes how even small inves...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ikena Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ikena Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
